the exciting new field of her2-low breast cancer
Published 2 years ago • 683 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
1:33
questions remaining in the field of her2-low breast cancer
-
2:05
latest news in her2-low breast cancer
-
0:31
remaining questions regarding her2-low breast cancer
-
1:36
is her2-low a distinct subtype of breast cancer?
-
1:17
clinical outcomes in women with metastatic her2-low breast cancer in the real world
-
0:45
the evolution of her2-low breast cancer from primary to recurrence
-
6:51
adcs for her2 and her2-low breast cancer
-
1:16
her2-low expression in breast cancer
-
0:32
highlights in her2-low breast cancer at sabcs 2022
-
1:10
the evolution of her2-low-positive breast cancer as a clinical subtype
-
0:56
her2-low status as a therapeutic target in advanced breast cancer
-
1:08
destiny-breast04: a ground-breaking trial in her2-low breast cancer
-
2:21
adcs for the treatment of her2-low breast cancer
-
1:19
remaining challenges regarding her2-low breast cancer
-
4:01
trastuzumab deruxtecan: a promising agent for treating her2-low breast cancer?
-
1:05
the genomic characterization of primary and metastatic her2-low breast cancers
-
2:01
destiny-breast04: practice-changing results for her2-low breast cancer
-
1:45
the comprehensive genomic characterization of her2-low breast cancer
-
0:41
investigating the influence of her2 low status in lbc